Lawrence Ganti is a seasoned executive and entrepreneur with 30 years of experience leading companies through transformations, transitions, and scale-ups. He has a unique toolbox of skills having served in the C-Suite for publicly listed companies, hired as an operator for start-ups ready to scale, and having Co-Founded multiple ventures. He has been a Co-Founder for Biotech, Agritech, Medical Device, Fashion & Apparel, and B2B SaaS companies.
Lawrence has a demonstrated track record of helping founders and venture capitalists scale their companies. Through mentorship, fundraising, and direct operating, he has raised over $1 billion of capital, launched million-dollar products, created award winning marketing campaigns, structured public private partnerships, and grew companies with award winning record results. Lawrence spent his formative years climbing the corporate ladder at pharma and chemicals giant, Merck. During his 16 year career with Merck, he lived and managed businesses in the US, Europe, Japan, China, India, Middle East, and Latin America. As the CEO of Latin America, he led a team of 3,000 employees driving $1.5 billion in revenues. His exceptional leadership has earned him numerous CEO Awards for Leadership, Business Performance, Talent Development, and Change Management.
Some of Lawrence’s achievements related to scaling ventures include: leading the scale-up of medical device start-up where he secured over $200m in non-dilutive investment from the US Government and subsequently served on the Presidential task force “Operation Warp Speed” as a key operator for the pandemic response. He subsequently raised a Series D round of $100m at a $2.1b valuation. He oversaw a 400% growth in manufacturing capacity and grew sales from $1m to $50m annually. He took the company public via a de-SPAC merger with JP Morgan and Goldman Sachs. The transaction eventually failed at the last minute due to founder dynamics. Lawrence exited under change of control dynamics with a mini-exit after raising an additional $200m in debt financing from Oaktree Capital.
Lawrence is an active angel investor. He currently supports founders in the Medical Apparel, AI Software, Materials Science, Deep Tech, AgriBio, Digital Health, and Medical Device sectors. Lawrence serves on the boards of numerous startups and serves as a Fractional CXO for multiple early-stage ventures. He is a published author on the topics of Transitioning from R&D to Commercialization and frequently writes for Forbes and FastCompany.
Lawrence started his career in Pharmaceutical Sales for Johnson & Johnson and then did ethnographic research for a joint initiative between McKinsey & Company and Harvard Business School.
Lawrence obtained his BA from Babson College, where he served as Class President and Editor in Chief of the Babson Free Press. He obtained his MBA from the International Institute for Management Development (IMD) in Lausanne, Switzerland. He is an alumni of various executive education programs at Wharton, Kellogg, INSEAD, MIT, and HKUST.